CRBP vs MGM · $102.3M cap vs P/E 64, rev $4.45B
Corbus Pharmaceuticals Holding (CRBP) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
Corbus Pharmaceuticals Holding (CRBP) is a biotechnology company listed on US.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
CRBP does not have a complete income-statement cache yet.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
CRBP currently screens at market cap $102.3M. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the CRBP and MGM stock pages for the full models.
Not investment advice.